{"symbol":"BSX","fiscalQuarter":"Q4-2021","reportDate":"2022-02-02","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2021","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 4.74%","keyNumbers":[{"metric":"EPS","actual":"$0.45","expected":"N/A","surprise":"+3.21%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Neutral","keyQuotes":["Management highlighted ongoing challenges in the supply chain.","They emphasized a commitment to innovation despite market pressures."],"summary":"Management acknowledged the impact of external factors on performance. They remain focused on long-term growth strategies."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock dropped 4.74%, likely reflecting investor concerns about ongoing supply chain challenges and the lack of revenue data. The absence of guidance may also have contributed to the negative market reaction.","metaDescription":"Boston Scientific (BSX) Q4 2021 earnings: EPS beat by 3.21%. Stock down 4.74%. Full breakdown."}}